IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $704,000 | -88.5% | 100,000 | -90.0% | 0.23% | -87.2% |
| Q1 2023 | $6,110,000 | -26.4% | 1,000,000 | -23.1% | 1.81% | -49.1% |
| Q4 2022 | $8,307,000 | -13.0% | 1,300,000 | +160.0% | 3.55% | +3.7% |
| Q4 2021 | $9,545,000 | -44.7% | 500,000 | -28.6% | 3.42% | -32.2% |
| Q3 2021 | $17,262,000 | +47.4% | 700,000 | +55.6% | 5.05% | +56.8% |
| Q2 2021 | $11,709,000 | -26.0% | 450,000 | -10.0% | 3.22% | -13.5% |
| Q1 2021 | $15,830,000 | -31.8% | 500,000 | 0.0% | 3.72% | -28.0% |
| Q4 2020 | $23,200,000 | +22.6% | 500,000 | -13.0% | 5.17% | -5.5% |
| Q3 2020 | $18,929,000 | +18.9% | 575,000 | -0.9% | 5.47% | +30.2% |
| Q2 2020 | $15,921,000 | +52.0% | 580,000 | +65.7% | 4.20% | +51.2% |
| Q1 2020 | $10,477,000 | -62.1% | 350,000 | -65.0% | 2.78% | -47.3% |
| Q4 2019 | $27,680,000 | +204.2% | 1,000,000 | +100.0% | 5.27% | +127.4% |
| Q3 2019 | $9,100,000 | +147.4% | 500,000 | +233.3% | 2.32% | +203.8% |
| Q2 2019 | $3,678,000 | -66.4% | 150,000 | -87.0% | 0.76% | -73.3% |
| Q1 2019 | $10,937,000 | +23.6% | 1,150,000 | +15.0% | 2.86% | -11.1% |
| Q4 2018 | $8,850,000 | +92.1% | 1,000,000 | +177.8% | 3.21% | +136.9% |
| Q2 2018 | $4,608,000 | -72.7% | 360,000 | -64.0% | 1.36% | -60.3% |
| Q1 2018 | $16,900,000 | +318.0% | 1,000,000 | +81.8% | 3.42% | +307.0% |
| Q2 2017 | $4,043,000 | – | 550,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |